INTERNATIONAL PATENT: RONDO THERAPEUTICS, INC. FILES APPLICATION FOR "BISPECIFIC ANTIBODIES THAT BIND TO CD28 AND NECTIN-4"

GENEVA, Nov. 18 -- RONDO THERAPEUTICS, INC. (25801 Industrial BoulevardSuite 500Hayward, California 94545) filed a patent application (PCT/US2025/027707) for "BISPECIFIC ANTIBODIES THAT BIND TO CD28 AND NECTIN-4" on May 05, 2025. With publication no. WO/2025/235357, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CLARKE, Starlynn (c/o Rondo Therapeutics, Inc.25801 Industrial BoulevardSuite 500Hayward, California 94545), RUGER, Katja (c/o Rondo Therapeutics, Inc.25801 Industrial BoulevardSuite 500Hayward, California 94545)...